Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transcription coregulator activity	MED15 SMARCD1 NCOA6 KMT2D SUPT20H MAML3 MED12	1.56e-05	562	30	7	GO:0003712
GeneOntologyMolecularFunction	transcription coactivator activity	SMARCD1 NCOA6 KMT2D MAML3 MED12	8.12e-05	303	30	5	GO:0003713
GeneOntologyMolecularFunction	nuclear vitamin D receptor binding	NCOA6 MED12	3.29e-04	18	30	2	GO:0042809
GeneOntologyMolecularFunction	molecular adaptor activity	MED15 GIGYF2 SMARCD1 NCOA6 KMT2D SUPT20H MAML3 MED12	6.73e-04	1356	30	8	GO:0060090
GeneOntologyMolecularFunction	chromatin binding	SMARCD1 NCOA6 EP400 ATRX NFAT5 MED12	6.99e-04	739	30	6	GO:0003682
GeneOntologyMolecularFunction	nuclear thyroid hormone receptor binding	NCOA6 MED12	1.19e-03	34	30	2	GO:0046966
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	MED15 SMARCD1 NCOA6 KMT2D SUPT20H MAML3 MED12	1.37e-03	1160	30	7	GO:0030674
GeneOntologyMolecularFunction	ATP-dependent chromatin remodeler activity	EP400 ATRX	1.41e-03	37	30	2	GO:0140658
GeneOntologyBiologicalProcess	DNA damage response	PAXIP1 FMN2 GIGYF2 SMARCD1 NCOA6 SUPT20H EP400 ATRX NFAT5 INTS7 EMSY	5.02e-08	959	30	11	GO:0006974
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	PAXIP1 MED15 NCOA6 ZFHX3 KMT2D SUPT20H ATRX NFAT5 LMX1A MAML3 MED12 THAP11	2.32e-07	1390	30	12	GO:0045944
GeneOntologyBiologicalProcess	positive regulation of DNA metabolic process	PAXIP1 CIZ1 FMN2 SMARCD1 EP400 ATRX	7.25e-06	333	30	6	GO:0051054
GeneOntologyBiologicalProcess	regulation of DNA metabolic process	PAXIP1 CIZ1 FMN2 SMARCD1 SUPT20H EP400 ATRX	1.30e-05	564	30	7	GO:0051052
GeneOntologyBiologicalProcess	DNA-templated transcription initiation	PAXIP1 MED15 SMARCD1 NCOA6 MED12	1.91e-05	231	30	5	GO:0006352
GeneOntologyBiologicalProcess	DNA repair	PAXIP1 FMN2 SMARCD1 SUPT20H EP400 ATRX EMSY	3.17e-05	648	30	7	GO:0006281
GeneOntologyBiologicalProcess	protein-DNA complex organization	PAXIP1 MED15 SMARCD1 KMT2D EP400 ATRX NFAT5 EMSY	6.64e-05	999	30	8	GO:0071824
GeneOntologyBiologicalProcess	DNA metabolic process	PAXIP1 CIZ1 FMN2 SMARCD1 SUPT20H EP400 ATRX EMSY	1.15e-04	1081	30	8	GO:0006259
GeneOntologyBiologicalProcess	positive regulation of transcription initiation by RNA polymerase II	PAXIP1 MED15 MED12	1.42e-04	70	30	3	GO:0060261
GeneOntologyBiologicalProcess	transcription initiation at RNA polymerase II promoter	PAXIP1 MED15 SMARCD1 MED12	1.46e-04	186	30	4	GO:0006367
GeneOntologyBiologicalProcess	positive regulation of DNA-templated transcription initiation	PAXIP1 MED15 MED12	1.89e-04	77	30	3	GO:2000144
GeneOntologyBiologicalProcess	signal transduction in response to DNA damage	PAXIP1 GIGYF2 ATRX INTS7	1.93e-04	200	30	4	GO:0042770
GeneOntologyBiologicalProcess	positive regulation of DNA-templated DNA replication	CIZ1 ATRX	2.12e-04	15	30	2	GO:2000105
GeneOntologyBiologicalProcess	regulation of transcription initiation by RNA polymerase II	PAXIP1 MED15 MED12	2.19e-04	81	30	3	GO:0060260
GeneOntologyBiologicalProcess	central nervous system development	CACNA1A SHROOM4 GIGYF2 NCOA6 POU6F2 ATRX LMX1A MED12	2.33e-04	1197	30	8	GO:0007417
GeneOntologyBiologicalProcess	chromatin organization	PAXIP1 SMARCD1 KMT2D EP400 ATRX NFAT5 EMSY	2.41e-04	896	30	7	GO:0006325
GeneOntologyBiologicalProcess	regulation of DNA-templated transcription initiation	PAXIP1 MED15 MED12	3.09e-04	91	30	3	GO:2000142
GeneOntologyBiologicalProcess	regulation of DNA repair	FMN2 SMARCD1 SUPT20H EP400	3.51e-04	234	30	4	GO:0006282
GeneOntologyBiologicalProcess	positive regulation of double-strand break repair	FMN2 SMARCD1 EP400	3.51e-04	95	30	3	GO:2000781
GeneOntologyBiologicalProcess	chromatin remodeling	PAXIP1 SMARCD1 KMT2D EP400 ATRX NFAT5	5.98e-04	741	30	6	GO:0006338
GeneOntologyBiologicalProcess	spinal cord development	CACNA1A GIGYF2 MED12	6.78e-04	119	30	3	GO:0021510
GeneOntologyBiologicalProcess	locomotory behavior	CACNA1A GIGYF2 ZFHX3 LMX1A	7.27e-04	284	30	4	GO:0007626
GeneOntologyCellularComponent	MLL3/4 complex	PAXIP1 NCOA6 KMT2D	5.24e-07	12	29	3	GO:0044666
GeneOntologyCellularComponent	nuclear protein-containing complex	PAXIP1 MED15 SMARCD1 NCOA6 KMT2D EP400 INTS7 MED12 THAP11	6.82e-05	1377	29	9	GO:0140513
GeneOntologyCellularComponent	chromatin	SMARCD1 ZFHX3 POU6F2 SUPT20H EP400 ATRX NFAT5 LMX1A THAP11	1.19e-04	1480	29	9	GO:0000785
GeneOntologyCellularComponent	histone methyltransferase complex	PAXIP1 NCOA6 KMT2D	1.52e-04	75	29	3	GO:0035097
GeneOntologyCellularComponent	methyltransferase complex	PAXIP1 NCOA6 KMT2D	4.44e-04	108	29	3	GO:0034708
GeneOntologyCellularComponent	transcription regulator complex	MED15 NCOA6 ZFHX3 NFAT5 THAP11	1.25e-03	596	29	5	GO:0005667
GeneOntologyCellularComponent	transferase complex	PAXIP1 NCOA6 KMT2D SUPT20H EP400 MED12	1.80e-03	963	29	6	GO:1990234
Domain	ARM-like	NALF1 INTS7 MED12 THAP11	8.71e-04	270	30	4	IPR011989
Domain	ZnF_U1	CIZ1 ZFHX3	9.86e-04	29	30	2	SM00451
Domain	Znf_U1	CIZ1 ZFHX3	9.86e-04	29	30	2	IPR003604
Domain	SNF2_N	EP400 ATRX	1.20e-03	32	30	2	PF00176
Domain	SNF2_N	EP400 ATRX	1.20e-03	32	30	2	IPR000330
Domain	Homeodomain-like	ZFHX3 POU6F2 EP400 LMX1A	1.87e-03	332	30	4	IPR009057
Domain	Homeobox	ZFHX3 POU6F2 LMX1A	6.14e-03	234	30	3	PF00046
Domain	HOMEOBOX_1	ZFHX3 POU6F2 LMX1A	6.29e-03	236	30	3	PS00027
Domain	HOX	ZFHX3 POU6F2 LMX1A	6.36e-03	237	30	3	SM00389
Domain	Homeobox_dom	ZFHX3 POU6F2 LMX1A	6.51e-03	239	30	3	IPR001356
Domain	HOMEOBOX_2	ZFHX3 POU6F2 LMX1A	6.51e-03	239	30	3	PS50071
Domain	ZF_PHD_2	KMT2D ATRX	1.02e-02	95	30	2	PS50016
Domain	-	ZFHX3 POU6F2 LMX1A	1.03e-02	283	30	3	1.10.10.60
Domain	ZF_PHD_1	KMT2D ATRX	1.04e-02	96	30	2	PS01359
Domain	Helicase_C	EP400 ATRX	1.27e-02	107	30	2	PF00271
Domain	HELICc	EP400 ATRX	1.27e-02	107	30	2	SM00490
Domain	Helicase_C	EP400 ATRX	1.30e-02	108	30	2	IPR001650
Domain	HELICASE_CTER	EP400 ATRX	1.32e-02	109	30	2	PS51194
Domain	HELICASE_ATP_BIND_1	EP400 ATRX	1.32e-02	109	30	2	PS51192
Pathway	WP_KLEEFSTRA_SYNDROME	PAXIP1 SMARCD1 NCOA6	1.54e-05	29	24	3	M48076
Pathway	REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES	PAXIP1 NCOA6 KMT2D	4.77e-05	42	24	3	M48018
Pathway	WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY	KMT2D EP400 ATRX MED12 THAP11	1.31e-04	301	24	5	MM15983
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION	MED15 NCOA6 MED12	3.77e-04	84	24	3	M1008
Pathway	REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION	PAXIP1 SMARCD1 NCOA6 KMT2D	8.23e-04	254	24	4	M27131
Pathway	REACTOME_ADIPOGENESIS	MED15 NCOA6 MED12	8.30e-04	110	24	3	M48259
Pathway	REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA	MED15 NCOA6 MED12	1.02e-03	118	24	3	M27316
Pathway	REACTOME_CHROMATIN_MODIFYING_ENZYMES	SMARCD1 KMT2D SUPT20H EP400	1.06e-03	272	24	4	M29619
Pathway	REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS	PAXIP1 NCOA6 KMT2D	1.12e-03	122	24	3	M29689
Pathway	REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES	PAXIP1 KMT2D	1.88e-03	38	24	2	MM17073
Pubmed	cDNAs with long CAG trinucleotide repeats from human brain.	PAXIP1 MED15 GIGYF2 KMT2D EP400 MAML3 MED12	4.05e-17	23	30	7	9225980
Pubmed	Interaction network of human early embryonic transcription factors.	PAXIP1 MED15 SMARCD1 NCOA6 ZFHX3 KMT2D EP400 MED12 EMSY	1.16e-11	351	30	9	38297188
Pubmed	PRC1 and PRC2 are not required for targeting of H2A.Z to developmental genes in embryonic stem cells.	PAXIP1 MED15 NCOA6 KMT2D EP400 EMSY	1.93e-11	65	30	6	22496869
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	PAXIP1 MED15 SMARCD1 NCOA6 KMT2D EP400 MED12 EMSY	5.66e-11	268	30	8	33640491
Pubmed	Human transcription factor protein interaction networks.	PAXIP1 MED15 GIGYF2 SMARCD1 NCOA6 ZFHX3 KMT2D SUPT20H EP400 ATRX EMSY THAP11	9.62e-10	1429	30	12	35140242
Pubmed	An Oct4-centered protein interaction network in embryonic stem cells.	MED15 SMARCD1 KMT2D EP400 MED12 EMSY	6.04e-09	167	30	6	20362541
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	CIZ1 MED15 GIGYF2 NCOA6 KMT2D EP400 MED12 EMSY	1.58e-08	549	30	8	38280479
Pubmed	Novel triplet repeat containing genes in human brain: cloning, expression, and length polymorphisms.	NALF1 DENND4B THAP11	2.02e-08	7	30	3	8325628
Pubmed	Knockdown of ALR (MLL2) reveals ALR target genes and leads to alterations in cell adhesion and growth.	PAXIP1 NCOA6 KMT2D	3.23e-08	8	30	3	17178841
Pubmed	Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination.	PAXIP1 NCOA6 KMT2D	1.65e-07	13	30	3	17761849
Pubmed	The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.	SMARCD1 NCOA6 KMT2D EP400 ATRX	2.29e-07	157	30	5	30186101
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	PAXIP1 MED15 SMARCD1 NCOA6 KMT2D EP400 MED12 EMSY THAP11	2.47e-07	1103	30	9	34189442
Pubmed	The BRCT-domain containing protein PTIP links PAX2 to a histone H3, lysine 4 methyltransferase complex.	PAXIP1 NCOA6 KMT2D	2.62e-07	15	30	3	17925232
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	AAK1 CIZ1 MED15 ZFHX3 SUPT20H EP400 ATRX INTS7 MED12 EMSY	2.89e-07	1497	30	10	31527615
Pubmed	H3K4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation.	PAXIP1 NCOA6 KMT2D	3.22e-07	16	30	3	24368734
Pubmed	Genetic interaction mapping in mammalian cells using CRISPR interference.	MED15 KMT2D EP400 MED12	3.74e-07	69	30	4	28481362
Pubmed	MLL3 and MLL4 Methyltransferases Bind to the MAFA and MAFB Transcription Factors to Regulate Islet β-Cell Function.	PAXIP1 NCOA6 KMT2D	3.91e-07	17	30	3	26180087
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	PAXIP1 NCOA6 KMT2D EP400 MED12 EMSY	4.14e-07	341	30	6	32971831
Pubmed	PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex.	PAXIP1 NCOA6 KMT2D	4.68e-07	18	30	3	17500065
Pubmed	Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy.	PAXIP1 NCOA6 KMT2D	6.54e-07	20	30	3	29785026
Pubmed	Targeted inactivation of MLL3 histone H3-Lys-4 methyltransferase activity in the mouse reveals vital roles for MLL3 in adipogenesis.	PAXIP1 NCOA6 KMT2D	6.54e-07	20	30	3	19047629
Pubmed	Structural basis for activity regulation of MLL family methyltransferases.	PAXIP1 NCOA6 KMT2D	8.82e-07	22	30	3	26886794
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	PAXIP1 CIZ1 NCOA6 KMT2D SUPT20H EP400 ATRX INTS7 EMSY	9.38e-07	1294	30	9	30804502
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	PAXIP1 MED15 SMARCD1 NCOA6 KMT2D SIK3 MAML3	9.54e-07	638	30	7	31182584
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	PAXIP1 CIZ1 MED15 KMT2D SUPT20H EP400	1.02e-06	398	30	6	35016035
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	SMARCD1 ZFHX3 KMT2D ATRX MED12	1.21e-06	220	30	5	35785414
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	PAXIP1 SUPT20H EP400 ATRX EMSY	1.27e-06	222	30	5	37071664
Pubmed	Exome Sequencing of Uterine Leiomyosarcomas Identifies Frequent Mutations in TP53, ATRX, and MED12.	ATRX MED12	2.16e-06	3	30	2	26891131
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	AAK1 GIGYF2 NCOA6 KMT2D EP400 ATRX EMSY	3.43e-06	774	30	7	15302935
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	NCOA6 ZFHX3 EP400 ATRX EMSY	4.15e-06	283	30	5	30585729
Pubmed	HOXA9 Reprograms the Enhancer Landscape to Promote Leukemogenesis.	PAXIP1 KMT2D	4.31e-06	4	30	2	30270123
Pubmed	Aurora kinase A regulates Survivin stability through targeting FBXL7 in gastric cancer drug resistance and prognosis.	ZFHX3 SUPT20H ATRX	4.79e-06	38	30	3	28218735
Pubmed	A PTIP-PA1 subcomplex promotes transcription for IgH class switching independently from the associated MLL3/MLL4 methyltransferase complex.	PAXIP1 KMT2D	7.18e-06	5	30	2	26744420
Pubmed	Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases.	NCOA6 KMT2D	1.08e-05	6	30	2	17021013
Pubmed	Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival.	PAXIP1 NCOA6 KMT2D	1.10e-05	50	30	3	37974198
Pubmed	Generation and analysis of 280,000 human expressed sequence tags.	GIGYF2 SMARCD1 SIK3 NALF1 NFAT5	1.48e-05	368	30	5	8889549
Pubmed	ASCOM controls farnesoid X receptor transactivation through its associated histone H3 lysine 4 methyltransferase activity.	NCOA6 KMT2D	1.51e-05	7	30	2	19556342
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	PAXIP1 CIZ1 MED15 SUPT20H EP400 MED12	1.62e-05	645	30	6	25281560
Pubmed	Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription.	SMARCD1 NCOA6 MED12	1.82e-05	59	30	3	28813667
Pubmed	FBXO42 facilitates Notch signaling activation and global chromatin relaxation by promoting K63-linked polyubiquitination of RBPJ.	SMARCD1 ATRX MAML3 EMSY	1.83e-05	183	30	4	36129980
Pubmed	Circular RNAs regulate neuron size and migration of midbrain dopamine neurons during development.	GIGYF2 LMX1A	2.01e-05	8	30	2	39117691
Pubmed	Behavioral effects of neonatal lesions on the cerebellar system.	CACNA1A LMX1A	2.01e-05	8	30	2	25907855
Pubmed	Mediator complex recruits epigenetic regulators via its two cyclin-dependent kinase subunits to repress transcription of immune response genes.	MED15 MED12	2.01e-05	8	30	2	23749998
Pubmed	Streamlined analysis schema for high-throughput identification of endogenous protein complexes.	MED15 INTS7 MED12	3.18e-05	71	30	3	20133760
Pubmed	Gene diversity patterns at 10 X-chromosomal loci in humans and chimpanzees.	ATRX MED12	3.22e-05	10	30	2	12777533
Pubmed	HIF1A employs CDK8-mediator to stimulate RNAPII elongation in response to hypoxia.	MED15 MED12	3.22e-05	10	30	2	23746844
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	AAK1 MED15 SUPT20H EP400 EMSY	3.63e-05	444	30	5	34795231
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	CIZ1 FMN2 SMARCD1 ZFHX3 SUPT20H SIK3 EP400	3.66e-05	1116	30	7	31753913
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	MED15 SMARCD1 EP400 MED12 EMSY	3.99e-05	453	30	5	29656893
Pubmed	Agonist-specific Protein Interactomes of Glucocorticoid and Androgen Receptor as Revealed by Proximity Mapping.	SMARCD1 NCOA6 KMT2D	4.22e-05	78	30	3	28611094
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	SMARCD1 C9orf43 KMT2D EP400 ATRX	4.71e-05	469	30	5	27634302
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	CACNA1A FMN2 ATRX NFAT5 INTS7	5.00e-05	475	30	5	31040226
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	NCOA6 KMT2D EP400	5.08e-05	83	30	3	28794006
Pubmed	A novel docking site on Mediator is critical for activation by VP16 in mammalian cells.	MED15 MED12	5.58e-05	13	30	2	14657022
Pubmed	The APC tumor suppressor counteracts beta-catenin activation and H3K4 methylation at Wnt target genes.	KMT2D EP400	5.58e-05	13	30	2	16510874
Pubmed	CDK8 is a positive regulator of transcriptional elongation within the serum response network.	MED15 MED12	5.58e-05	13	30	2	20098423
Pubmed	A genome-wide association study for reading and language abilities in two population cohorts.	ZFHX3 NALF1	5.58e-05	13	30	2	23738518
Pubmed	The SCF-FBXW7 E3 ubiquitin ligase triggers degradation of histone 3 lysine 4 methyltransferase complex component WDR5 to prevent mitotic slippage.	PAXIP1 KMT2D	5.58e-05	13	30	2	36395886
Pubmed	Structure, function, and activator-induced conformations of the CRSP coactivator.	MED15 MED12	6.50e-05	14	30	2	11834832
Pubmed	Activating signal cointegrator 2 belongs to a novel steady-state complex that contains a subset of trithorax group proteins.	NCOA6 KMT2D	6.50e-05	14	30	2	12482968
Pubmed	Cooperative activity of cdk8 and GCN5L within Mediator directs tandem phosphoacetylation of histone H3.	MED15 MED12	7.50e-05	15	30	2	18418385
Pubmed	Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program.	KMT2D EP400	7.50e-05	15	30	2	16510875
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	MED15 SMARCD1 SUPT20H ATRX INTS7	8.61e-05	533	30	5	30554943
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	AAK1 CIZ1 MED15 GIGYF2 PDE5A ATRX THAP11	1.06e-04	1321	30	7	27173435
Pubmed	A census of human transcription factors: function, expression and evolution.	ZFHX3 POU6F2 KMT2D NFAT5 LMX1A THAP11	1.08e-04	908	30	6	19274049
Pubmed	ATAC and Mediator coactivators form a stable complex and regulate a set of non-coding RNA genes.	MED15 MED12 EMSY	1.08e-04	107	30	3	20508642
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	PAXIP1 GIGYF2 SMARCD1 SUPT20H ATRX MED12 EMSY	1.09e-04	1327	30	7	32694731
Pubmed	Engrailed transcription factors direct excitatory cerebellar neuron diversity and survival.	ZFHX3 LMX1A	1.09e-04	18	30	2	38912572
Pubmed	An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis.	MED15 MED12	1.22e-04	19	30	2	16799563
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	AAK1 CIZ1 GIGYF2 EP400 ATRX EMSY	1.26e-04	934	30	6	33916271
Pubmed	FBXW7 Triggers Degradation of KMT2D to Favor Growth of Diffuse Large B-cell Lymphoma Cells.	NCOA6 KMT2D	1.35e-04	20	30	2	32350066
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	CIZ1 GIGYF2 NCOA6 EP400 ATRX EMSY	1.42e-04	954	30	6	36373674
Pubmed	Quantitative dissection and stoichiometry determination of the human SET1/MLL histone methyltransferase complexes.	PAXIP1 NCOA6 KMT2D	1.48e-04	119	30	3	23508102
Pubmed	Composite co-activator ARC mediates chromatin-directed transcriptional activation.	MED15 MED12	1.80e-04	23	30	2	10235267
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	MED15 SMARCD1 SUPT20H EP400 ATRX MED12	1.97e-04	1014	30	6	32416067
Pubmed	MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.	SMARCD1 SUPT20H EP400 EMSY	1.99e-04	339	30	4	30415952
Pubmed	BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors.	SUPT20H EP400 THAP11	2.10e-04	134	30	3	25452129
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	AAK1 CACNA1A FMN2 GIGYF2	2.17e-04	347	30	4	17114649
Pubmed	Cerebellar dysfunction and schizophrenia-like behavior in Ebp1-deficient mice.	CACNA1A LMX1A	2.31e-04	26	30	2	35165395
Pubmed	Mediator complex proximal Tail subunit MED30 is critical for Mediator core stability and cardiomyocyte transcriptional network.	MED15 MED12	2.31e-04	26	30	2	34506481
Pubmed	Proteomic analysis of FOXP proteins reveals interactions between cortical transcription factors associated with neurodevelopmental disorders.	NFAT5 EMSY	2.68e-04	28	30	2	29365100
Pubmed	Mediator and cohesin connect gene expression and chromatin architecture.	MED15 MED12	2.68e-04	28	30	2	20720539
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	SMARCD1 SUPT20H SIK3 EP400 MED12 THAP11	2.80e-04	1082	30	6	38697112
Pubmed	Genome-wide characterisation of Foxa1 binding sites reveals several mechanisms for regulating neuronal differentiation in midbrain dopamine cells.	POU6F2 LMX1A	3.08e-04	30	30	2	25804738
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PAXIP1 NCOA6 KMT2D EP400 MED12 THAP11	3.13e-04	1105	30	6	35748872
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	SMARCD1 ZFHX3 NFAT5 LMX1A MAML3	3.24e-04	709	30	5	22988430
Pubmed	Identification and characterization of a novel human PP1 phosphatase complex.	PAXIP1 KMT2D	3.29e-04	31	30	2	20516061
Pubmed	The SCF-Fbw7 ubiquitin ligase degrades MED13 and MED13L and regulates CDK8 module association with Mediator.	MED15 MED12	3.29e-04	31	30	2	23322298
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	CIZ1 SMARCD1 EP400 ATRX	3.52e-04	394	30	4	27248496
Pubmed	MED1/TRAP220 exists predominantly in a TRAP/ Mediator subpopulation enriched in RNA polymerase II and is required for ER-mediated transcription.	MED15 MED12	3.97e-04	34	30	2	15989967
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	GIGYF2 EP400 NFAT5 DENND4B	3.98e-04	407	30	4	12693553
Pubmed	The cell proliferation antigen Ki-67 organises heterochromatin.	KMT2D EP400 INTS7 MED12	4.09e-04	410	30	4	26949251
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	GIGYF2 ZFHX3 KMT2D MED12	4.40e-04	418	30	4	34709266
Pubmed	Fgf and Esrrb integrate epigenetic and transcriptional networks that regulate self-renewal of trophoblast stem cells.	EP400 ATRX INTS7	4.76e-04	177	30	3	26206133
Pubmed	Temporal regulation of the Mediator complex during muscle proliferation, differentiation, regeneration, aging, and disease.	MED15 MED12	5.23e-04	39	30	2	38690566
Pubmed	Prediction of the coding sequences of unidentified human genes. V. The coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by analysis of cDNA clones from human cell line KG-1.	NCOA6 MED12	5.78e-04	41	30	2	8724849
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	CIZ1 SMARCD1 ZFHX3 NFAT5 LMX1A	5.88e-04	808	30	5	20412781
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	MED15 NCOA6 KMT2D MAML3	6.15e-04	457	30	4	32344865
Pubmed	Functional genomic landscape of cancer-intrinsic evasion of killing by T cells.	PAXIP1 SUPT20H MED12 THAP11	6.15e-04	457	30	4	32968282
Pubmed	The Dual Estrogen Receptor α Inhibitory Effects of the Tissue-Selective Estrogen Complex for Endometrial and Breast Safety.	NCOA6 MED12	6.35e-04	43	30	2	26487511
Interaction	FEV interactions	PAXIP1 NCOA6 ZFHX3 KMT2D SUPT20H EP400 ATRX EMSY	2.41e-10	203	28	8	int:FEV
Interaction	MED23 interactions	PAXIP1 MED15 NCOA6 ZFHX3 SUPT20H EP400 MED12 EMSY	2.05e-09	266	28	8	int:MED23
Interaction	SOX9 interactions	PAXIP1 SMARCD1 NCOA6 KMT2D EP400 MED12	3.68e-09	97	28	6	int:SOX9
Interaction	HNF4A interactions	PAXIP1 SMARCD1 NCOA6 KMT2D EP400 ATRX EMSY	7.56e-08	275	28	7	int:HNF4A
Interaction	EGR2 interactions	PAXIP1 NCOA6 ZFHX3 KMT2D EP400 EMSY	1.10e-07	171	28	6	int:EGR2
Interaction	HNF1B interactions	PAXIP1 SMARCD1 ZFHX3 POU6F2 KMT2D EP400	2.06e-07	190	28	6	int:HNF1B
Interaction	TP53BP1 interactions	PAXIP1 MED15 SMARCD1 NCOA6 POU6F2 EP400 MED12 EMSY	4.43e-07	533	28	8	int:TP53BP1
Interaction	AR interactions	PAXIP1 MED15 SMARCD1 NCOA6 ZFHX3 KMT2D EP400 ATRX MED12 EMSY	4.65e-07	992	28	10	int:AR
Interaction	ELF4 interactions	SMARCD1 KMT2D SUPT20H EP400 EMSY	4.91e-07	115	28	5	int:ELF4
Interaction	NFIX interactions	PAXIP1 SMARCD1 ZFHX3 KMT2D EP400 EMSY	5.85e-07	227	28	6	int:NFIX
Interaction	ETS1 interactions	PAXIP1 SMARCD1 KMT2D EP400 EMSY	6.32e-07	121	28	5	int:ETS1
Interaction	PAX9 interactions	PAXIP1 SMARCD1 NCOA6 ZFHX3 KMT2D	9.02e-07	130	28	5	int:PAX9
Interaction	TPRX2 interactions	PAXIP1 SMARCD1 NCOA6 KMT2D	1.04e-06	56	28	4	int:TPRX2
Interaction	CRX interactions	PAXIP1 MED15 ZFHX3 KMT2D EP400 MED12	1.13e-06	254	28	6	int:CRX
Interaction	ESRRB interactions	MED15 SMARCD1 KMT2D EP400 INTS7 MED12	1.35e-06	262	28	6	int:ESRRB
Interaction	ELF5 interactions	PAXIP1 SMARCD1 KMT2D INTS7 EMSY	1.66e-06	147	28	5	int:ELF5
Interaction	TLX3 interactions	PAXIP1 SMARCD1 NCOA6 ZFHX3 POU6F2 KMT2D	2.48e-06	291	28	6	int:TLX3
Interaction	HCFC1 interactions	PAXIP1 MED15 NCOA6 KMT2D EP400 THAP11	2.58e-06	293	28	6	int:HCFC1
Interaction	CEBPA interactions	PAXIP1 MED15 SMARCD1 NCOA6 KMT2D EP400 INTS7 MED12 EMSY THAP11	3.67e-06	1245	28	10	int:CEBPA
Interaction	FOS interactions	PAXIP1 SMARCD1 NCOA6 KMT2D EP400 NFAT5	3.71e-06	312	28	6	int:FOS
Interaction	LHX2 interactions	PAXIP1 SMARCD1 ZFHX3 KMT2D EP400	4.85e-06	183	28	5	int:LHX2
Interaction	MEN1 interactions	PAXIP1 GIGYF2 SMARCD1 NCOA6 KMT2D EP400 ATRX MED12 EMSY	6.52e-06	1029	28	9	int:MEN1
Interaction	KLF5 interactions	PAXIP1 SMARCD1 NCOA6 KMT2D EP400	6.61e-06	195	28	5	int:KLF5
Interaction	MAFA interactions	PAXIP1 NCOA6 KMT2D	6.87e-06	27	28	3	int:MAFA
Interaction	TADA2A interactions	PAXIP1 MED15 SUPT20H MED12 EMSY	7.12e-06	198	28	5	int:TADA2A
Interaction	GATA2 interactions	PAXIP1 SMARCD1 NCOA6 ZFHX3 KMT2D	7.29e-06	199	28	5	int:GATA2
Interaction	SOX10 interactions	PAXIP1 SMARCD1 POU6F2 KMT2D	7.66e-06	92	28	4	int:SOX10
Interaction	SOX17 interactions	PAXIP1 SMARCD1 NCOA6 KMT2D	8.70e-06	95	28	4	int:SOX17
Interaction	PAX6 interactions	PAXIP1 SMARCD1 NCOA6 ZFHX3 KMT2D EP400	9.25e-06	366	28	6	int:PAX6
Interaction	HDAC1 interactions	GIGYF2 SMARCD1 ZFHX3 KMT2D EP400 ATRX MED12 EMSY THAP11	1.19e-05	1108	28	9	int:HDAC1
Interaction	ERG interactions	PAXIP1 SMARCD1 NCOA6 KMT2D EMSY	1.27e-05	223	28	5	int:ERG
Interaction	SUPT5H interactions	PDE5A KMT2D EP400 ATRX INTS7 MAML3	1.71e-05	408	28	6	int:SUPT5H
Interaction	TBR1 interactions	PAXIP1 SMARCD1 ZFHX3 KMT2D	1.73e-05	113	28	4	int:TBR1
Interaction	NUP43 interactions	CIZ1 NCOA6 ZFHX3 KMT2D EP400 MED12 EMSY	1.79e-05	625	28	7	int:NUP43
Interaction	TBXT interactions	PAXIP1 SMARCD1 NCOA6 KMT2D	1.92e-05	116	28	4	int:TBXT
Interaction	ASF1A interactions	NCOA6 KMT2D EP400 ATRX EMSY	2.15e-05	249	28	5	int:ASF1A
Interaction	FBXW7 interactions	PAXIP1 MED15 SHROOM4 GIGYF2 NCOA6 KMT2D EP400 MED12 THAP11	2.48e-05	1215	28	9	int:FBXW7
Interaction	PAX7 interactions	PAXIP1 SMARCD1 ZFHX3 KMT2D	2.49e-05	124	28	4	int:PAX7
Interaction	PML interactions	PAXIP1 AAK1 MED15 SUPT20H EP400 ATRX INTS7 EMSY	2.78e-05	933	28	8	int:PML
Interaction	MYB interactions	PAXIP1 ZFHX3 KMT2D EMSY	3.28e-05	133	28	4	int:MYB
Interaction	TLX2 interactions	PAXIP1 ZFHX3 POU6F2 KMT2D	4.24e-05	142	28	4	int:TLX2
Interaction	RBBP5 interactions	PAXIP1 SMARCD1 NCOA6 KMT2D EMSY	4.25e-05	287	28	5	int:RBBP5
Interaction	NCOA6 interactions	PAXIP1 MED15 NCOA6 KMT2D	4.60e-05	145	28	4	int:NCOA6
Interaction	PAGR1 interactions	PAXIP1 NCOA6 KMT2D	4.78e-05	51	28	3	int:PAGR1
Interaction	SP7 interactions	PAXIP1 SMARCD1 NCOA6 KMT2D EP400	5.59e-05	304	28	5	int:SP7
Interaction	PPARG interactions	PAXIP1 GIGYF2 SMARCD1 NCOA6 KMT2D	5.85e-05	307	28	5	int:PPARG
Interaction	YAP1 interactions	CIZ1 MED15 GIGYF2 SMARCD1 NCOA6 KMT2D NFAT5 MED12	8.67e-05	1095	28	8	int:YAP1
Interaction	TLX1 interactions	PAXIP1 SMARCD1 ZFHX3 KMT2D	9.56e-05	175	28	4	int:TLX1
Interaction	TEAD1 interactions	PAXIP1 SMARCD1 ZFHX3 KMT2D	9.77e-05	176	28	4	int:TEAD1
Interaction	GCM1 interactions	PAXIP1 SMARCD1 KMT2D	1.13e-04	68	28	3	int:GCM1
Interaction	LHX3 interactions	PAXIP1 SMARCD1 KMT2D LMX1A	1.18e-04	185	28	4	int:LHX3
Interaction	NFIA interactions	PAXIP1 MED15 SMARCD1 KMT2D	1.26e-04	188	28	4	int:NFIA
Interaction	MYOD1 interactions	PAXIP1 SMARCD1 KMT2D EP400	1.42e-04	194	28	4	int:MYOD1
Interaction	SETD1B interactions	PAXIP1 NCOA6 KMT2D	1.52e-04	75	28	3	int:SETD1B
Interaction	XKRX interactions	SIK3 ATRX	1.68e-04	14	28	2	int:XKRX
Interaction	IRF4 interactions	PAXIP1 SMARCD1 KMT2D	2.20e-04	85	28	3	int:IRF4
Interaction	GSC interactions	PAXIP1 ZFHX3 KMT2D	2.35e-04	87	28	3	int:GSC
Interaction	KLF3 interactions	ZFHX3 KMT2D EP400 EMSY	2.64e-04	228	28	4	int:KLF3
Interaction	FOXI1 interactions	PAXIP1 SMARCD1 KMT2D	2.78e-04	92	28	3	int:FOXI1
Interaction	MED7 interactions	MED15 EP400 MED12	2.78e-04	92	28	3	int:MED7
Interaction	HCFC2 interactions	PAXIP1 NCOA6 KMT2D	2.78e-04	92	28	3	int:HCFC2
Interaction	NR3C1 interactions	PAXIP1 MED15 SMARCD1 NCOA6 KMT2D SIK3 MAML3	2.92e-04	974	28	7	int:NR3C1
Interaction	KLF6 interactions	SUPT20H EP400 EMSY	3.05e-04	95	28	3	int:KLF6
Interaction	TFCP2L1 interactions	SMARCD1 EP400 EMSY	3.45e-04	99	28	3	int:TFCP2L1
Interaction	LHX1 interactions	SMARCD1 KMT2D SUPT20H	3.87e-04	103	28	3	int:LHX1
Interaction	UTY interactions	NCOA6 KMT2D	4.63e-04	23	28	2	int:UTY
Interaction	ASH2L interactions	PAXIP1 NCOA6 KMT2D EMSY	4.67e-04	265	28	4	int:ASH2L
Interaction	EN1 interactions	PAXIP1 KMT2D EP400	4.69e-04	110	28	3	int:EN1
Interaction	PAX8 interactions	PAXIP1 SMARCD1 KMT2D	4.82e-04	111	28	3	int:PAX8
Interaction	RELA interactions	MED15 NCOA6 ZFHX3 POU6F2 KMT2D	4.92e-04	485	28	5	int:RELA
Interaction	PLAC1 interactions	SUPT20H EP400	5.04e-04	24	28	2	int:PLAC1
Interaction	RCOR1 interactions	GIGYF2 ZFHX3 KMT2D MED12 THAP11	5.35e-04	494	28	5	int:RCOR1
Interaction	ZNF335 interactions	NCOA6 EMSY	5.48e-04	25	28	2	int:ZNF335
Interaction	TNRC6A interactions	GIGYF2 SMARCD1 NCOA6 MED12	5.74e-04	280	28	4	int:TNRC6A
Interaction	ELK3 interactions	SUPT20H EP400 EMSY	6.05e-04	120	28	3	int:ELK3
Interaction	TRRAP interactions	MED15 SUPT20H EP400 INTS7 MED12 THAP11	6.40e-04	790	28	6	int:TRRAP
Interaction	KLF15 interactions	MED15 KMT2D EP400 EMSY	6.55e-04	290	28	4	int:KLF15
Interaction	GET3 interactions	CACNA1A ZFHX3 EMSY	7.64e-04	130	28	3	int:GET3
Interaction	KMT2B interactions	PAXIP1 NCOA6 KMT2D	7.64e-04	130	28	3	int:KMT2B
Interaction	MED15 interactions	MED15 NCOA6 MED12	7.81e-04	131	28	3	int:MED15
Interaction	CXXC1 interactions	PAXIP1 NCOA6 KMT2D	7.98e-04	132	28	3	int:CXXC1
Interaction	KMT2C interactions	PAXIP1 NCOA6 KMT2D	8.34e-04	134	28	3	int:KMT2C
Interaction	KMT2A interactions	PAXIP1 MED15 NCOA6 KMT2D	8.81e-04	314	28	4	int:KMT2A
Interaction	NR1H4 interactions	SMARCD1 NCOA6	9.00e-04	32	28	2	int:NR1H4
Interaction	NFIB interactions	PAXIP1 SMARCD1 KMT2D	9.86e-04	142	28	3	int:NFIB
Interaction	RNF2 interactions	PAXIP1 MED15 NCOA6 KMT2D EP400 EMSY	1.03e-03	866	28	6	int:RNF2
Interaction	SLX4 interactions	PAXIP1 SUPT20H EP400 ATRX EMSY	1.04e-03	572	28	5	int:SLX4
Interaction	KLF8 interactions	KMT2D SUPT20H EP400 EMSY	1.05e-03	329	28	4	int:KLF8
Interaction	BOD1L1 interactions	PAXIP1 NCOA6 KMT2D	1.13e-03	149	28	3	int:BOD1L1
Interaction	POU5F1 interactions	PAXIP1 GIGYF2 ZFHX3 EP400 EMSY	1.14e-03	584	28	5	int:POU5F1
Interaction	ZBTB4 interactions	POU6F2 ATRX	1.14e-03	36	28	2	int:ZBTB4
Interaction	PPIA interactions	PAXIP1 SHROOM4 SMARCD1 NCOA6 EP400 MED12	1.18e-03	888	28	6	int:PPIA
Interaction	PHF21A interactions	GIGYF2 ZFHX3 KMT2D THAP11	1.22e-03	343	28	4	int:PHF21A
Interaction	DLL1 interactions	POU6F2 THAP11	1.27e-03	38	28	2	int:DLL1
Interaction	H3C14 interactions	NCOA6 KMT2D ATRX	1.29e-03	156	28	3	int:H3C14
Interaction	CCT8L2 interactions	CIZ1 ATRX THAP11	1.32e-03	157	28	3	int:CCT8L2
Interaction	KDM6A interactions	PAXIP1 NCOA6 KMT2D	1.44e-03	162	28	3	int:KDM6A
Interaction	UPF2 interactions	CIZ1 GIGYF2 SMARCD1	1.44e-03	162	28	3	int:UPF2
Interaction	PAXIP1 interactions	PAXIP1 NCOA6 KMT2D INTS7	1.45e-03	359	28	4	int:PAXIP1
Interaction	XRCC6 interactions	PAXIP1 NCOA6 ZFHX3 EP400 ATRX EMSY	1.48e-03	928	28	6	int:XRCC6
Cytoband	Ensembl 112 genes in cytogenetic band chr16q22	ZFHX3 NFAT5 THAP11	2.34e-04	183	30	3	chr16q22
GeneFamily	Ataxins\|Trinucleotide repeat containing	PAXIP1 MED15 GIGYF2 KMT2D EP400 MAML3 MED12	4.41e-16	25	21	7	775
GeneFamily	Cyclins\|Mediator complex	MED15 MED12	6.64e-04	33	21	2	1061
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP	PAXIP1 CIZ1 NCOA6 SUPT20H ATRX NFAT5 INTS7 DENND4B	4.89e-05	1215	30	8	M41122
Coexpression	GSE14308_TH17_VS_INDUCED_TREG_UP	SUPT20H SIK3 ATRX NFAT5	7.72e-05	200	30	4	M3385
Coexpression	GSE411_100MIN_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN	CIZ1 KMT2D SUPT20H MED12	7.72e-05	200	30	4	M5995
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000	PDE5A NCOA6 ZFHX3 POU6F2 SIK3 ATRX MAML3 EMSY	4.90e-05	985	30	8	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000
ToppCell	Control-Neu_4\|World / 5 Neutrophil clusters in COVID-19 patients	CIZ1 MED15 CACNA1A EMSY	6.83e-06	184	30	4	ce7f044956613118ee2e9fb6af2455c3166cb414
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FMN2 POU6F2 NALF1 MAML3	6.98e-06	185	30	4	34fcfd635c828dad9643bbf1c908d79282d6f5d9
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FMN2 POU6F2 NALF1 MAML3	6.98e-06	185	30	4	8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1A FMN2 PDE5A ATRX	8.58e-06	195	30	4	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	368C-Fibroblasts-Fibroblast-F-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	SHROOM4 ZNF853 LMX1A	1.35e-04	149	30	3	9286bc56ff2e245630537a0bda5f1a1e17be863a
ToppCell	368C-Fibroblasts-Fibroblast-F\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	SHROOM4 ZNF853 LMX1A	1.35e-04	149	30	3	f53151d9e5e724a61be0ee6a8c740d1990f28d5f
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FMN2 PDE5A ZFHX3	1.44e-04	152	30	3	0cb5f4dfae04e3f4eba502bbf229007d5fa3884d
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FMN2 PDE5A ZFHX3	1.44e-04	152	30	3	ba89ffb5a8bb33c188f854f54b39123b6d73496a
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZFHX3 LMX1A MAML3	1.80e-04	164	30	3	43630a448f4369fa9e4e3eccdf3b9f29cec16c39
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZFHX3 LMX1A MAML3	1.80e-04	164	30	3	46208f18325976c89f572f6627aea0582142b92d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZFHX3 LMX1A MAML3	1.80e-04	164	30	3	108fbecb56d69a675d6ce6e826a873ae528f2fd7
ToppCell	5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EECs\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNA1A POU6F2 LMX1A	1.83e-04	165	30	3	4b4e75ad0eb0a6b00c30a000ec6267e23ba2e496
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CACNA1A PDE5A ZFHX3	2.10e-04	173	30	3	fc2602b2ce051cd4c33957d7e3d041ff8a529883
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CACNA1A PDE5A ZFHX3	2.10e-04	173	30	3	901b8e6909c1f3849906fad9cee17b8f0bab050d
ToppCell	5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNA1A FMN2 LMX1A	2.17e-04	175	30	3	182e45f5c02214d6b9f317ff5dc43af8b42de978
ToppCell	Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)\|Adult / Lineage, Cell type, age group and donor	CACNA1A FMN2 NALF1	2.17e-04	175	30	3	4db1a3c284488b3f6de7568363f176d74e2a4587
ToppCell	Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231\|Adult / Lineage, Cell type, age group and donor	CACNA1A FMN2 NALF1	2.17e-04	175	30	3	8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18
ToppCell	3'-Pediatric_IBD-SmallIntestine-Epithelial-neuro-epithelial\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNA1A FMN2 LMX1A	2.21e-04	176	30	3	fb718a6b07aa5d56600263280afa530bcb63db42
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PAXIP1 MED15 PDE5A	2.29e-04	178	30	3	fcbbcc44271515de1969b4732b6441c012693d5f
ToppCell	COVID-19-kidney-Epi_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FMN2 POU6F2 NALF1	2.29e-04	178	30	3	544379f5a6145429762258d426b876bb36c112f5
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7\|TCGA-Colorectal / Sample_Type by Project: Shred V9	SHROOM4 NCOA6 ZNF853	2.29e-04	178	30	3	edc76b8f15056ec1c9a1c61a048b6331a92592d6
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1A FMN2 LMX1A	2.29e-04	178	30	3	30ca37f70d267cc9b40ca3e211f16d30360c3e6b
ToppCell	3'-Pediatric_IBD-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNA1A FMN2 LMX1A	2.32e-04	179	30	3	f2e8fc975c30992611630197b79daaeef7c4211d
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FMN2 POU6F2 MAML3	2.48e-04	183	30	3	848fc6dd129150897ee339343e83c645b6e779eb
ToppCell	RA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	CACNA1A PDE5A NALF1	2.48e-04	183	30	3	cae2ee08f985a6f005b4b8e959e465350315156a
ToppCell	Control-immature_Neutrophil-\|Control / Disease condition and Cell class	MED15 CACNA1A EMSY	2.52e-04	184	30	3	c4e8ba82a6aa76c46f05a71d5f1c7926555318cf
ToppCell	PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MED15 CACNA1A EMSY	2.52e-04	184	30	3	a8c6028d745aaa6ee7842259238694cb50ce0526
ToppCell	PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MED15 CACNA1A EMSY	2.52e-04	184	30	3	081d045f3bc98a36f342de7d50f39c9a888dd7eb
ToppCell	Control-Myeloid_G-immature_Neutrophil\|Control / Disease group, lineage and cell class	MED15 CACNA1A EMSY	2.52e-04	184	30	3	45f873236f7e90fb78c8e291d3b5b92d121acec9
ToppCell	Control-immature_Neutrophil\|Control / Disease condition and Cell class	MED15 CACNA1A EMSY	2.52e-04	184	30	3	2fdae5c6b3eb2232881d933a8c1061fda3623016
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1A NALF1 LMX1A	2.52e-04	184	30	3	7d9bcdaff8cbea4c50ab7db0f8e01f6bbd0ef593
ToppCell	PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	MED15 CACNA1A EMSY	2.52e-04	184	30	3	84c20730cd92b9aaa50077d7b625e37e7f9e91d2
ToppCell	PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MED15 CACNA1A EMSY	2.52e-04	184	30	3	d31d4116d1d196633784863781fa45673607a421
ToppCell	CV-Moderate-7\|Moderate / Virus stimulation, Condition and Cluster	KMT2D NFAT5 DENND4B	2.56e-04	185	30	3	a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	GIGYF2 ATRX NFAT5	2.60e-04	186	30	3	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	POU6F2 NALF1 MAML3	2.68e-04	188	30	3	874404a4fd9aa42873f6c53dc42da22d3b0fdb9e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	POU6F2 NALF1 MAML3	2.68e-04	188	30	3	b21e93a70583c30d05c0833cd3d4d4bca44a039e
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SIK3 NFAT5 MAML3	2.90e-04	193	30	3	779276e775cb2492e8dd36436295a536084a6415
ToppCell	Control-NK_CD56bright\|Control / Disease condition and Cell class	ZFHX3 ZNF853 MAML3	2.90e-04	193	30	3	8b1e7a226a6057e1097c1525984127b54e823876
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE5A ZFHX3 NALF1	2.94e-04	194	30	3	ab9cad697f9209d2889bc02b43b502dfeb2ebfef
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE5A ZFHX3 NALF1	2.94e-04	194	30	3	5c3b2b05d1e4f146551fe4c920263d8e6ca34de3
ToppCell	facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PAXIP1 PDE5A NALF1	2.99e-04	195	30	3	bd8e24dd598990204998d1dd853ba7a53dc0107e
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FMN2 POU6F2 NALF1	2.99e-04	195	30	3	2e1df01bf6e4e98e6cd9fb50926e34c5077b8666
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1A FMN2 ATRX	2.99e-04	195	30	3	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	Tracheal-10x3prime_v2-Epithelial-Epi_airway_neuro-secretory\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1A FMN2 MAML3	3.08e-04	197	30	3	ff4df77117165b6b25315e29b0722cc136eba607
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1A NALF1 ZNF853	3.12e-04	198	30	3	d6812494874be0c14361ac2ac3e418b335bb8f55
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CACNA1A FMN2 NALF1	3.12e-04	198	30	3	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CACNA1A FMN2 NALF1	3.12e-04	198	30	3	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CACNA1A FMN2 NALF1	3.12e-04	198	30	3	4ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCell	TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma\|TCGA-Bile_Duct / Sample_Type by Project: Shred V9	CIZ1 MED15 SMARCD1	3.22e-04	200	30	3	ad2a6da0b1ae7a9212a3c91e5eec4baa7481d8dc
ToppCell	TCGA-Bile_Duct-Primary_Tumor\|TCGA-Bile_Duct / Sample_Type by Project: Shred V9	CIZ1 MED15 SMARCD1	3.22e-04	200	30	3	0350e5ffd36033099b7e32a1fdd790fff99790dc
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	AAK1 CACNA1A NALF1	3.22e-04	200	30	3	48d801219bc771d6c7e151dc88ca4c179988de85
Computational	Neighborhood of ATRX	PAXIP1 POU6F2 SIK3 EP400 ATRX	6.10e-05	215	22	5	MORF_ATRX
Computational	Neighborhood of MSH3	PAXIP1 POU6F2 EP400 ATRX NFAT5	1.09e-04	243	22	5	MORF_MSH3
Computational	Neighborhood of BRCA1	PAXIP1 POU6F2 EP400 ATRX NFAT5	1.58e-04	263	22	5	MORF_BRCA1
Computational	Neighborhood of CDC2L5	PAXIP1 SIK3 EP400 ATRX	1.77e-04	142	22	4	MORF_CDC2L5
Computational	Neighborhood of REV3L	PAXIP1 EP400 ATRX	2.13e-04	58	22	3	MORF_REV3L
Computational	Neighborhood of RUNX1	PAXIP1 POU6F2 EP400 ATRX	2.31e-04	152	22	4	MORF_RUNX1
Computational	Neighborhood of FANCG	PAXIP1 KMT2D SIK3 ATRX	3.30e-04	167	22	4	MORF_FANCG
Computational	Neighborhood of PSMF1	PAXIP1 POU6F2 EP400 ATRX	3.30e-04	167	22	4	MORF_PSMF1
Computational	Neighborhood of RFC5	PAXIP1 EP400 ATRX	5.13e-04	78	22	3	MORF_RFC5
Computational	Neighborhood of PPP5C	PAXIP1 EP400 ATRX	8.05e-04	91	22	3	MORF_PPP5C
Computational	Neighborhood of BCL2	PAXIP1 AAK1 POU6F2 ATRX	9.83e-04	223	22	4	MORF_BCL2
Computational	Neighborhood of ERCC2	PAXIP1 SIK3 ATRX	1.19e-03	104	22	3	MORF_ERCC2
Computational	Neighborhood of MT4	PAXIP1 AAK1 SIK3 ATRX	1.44e-03	247	22	4	MORF_MT4
Drug	Dipivefrin hydrochloride [64019-93-8]; Up 200; 10.4uM; HL60; HG-U133A	CIZ1 MED15 SIK3 EP400 DENND4B	3.55e-06	180	30	5	1752_UP
Drug	2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A_EA	MED15 SUPT20H EP400 NFAT5 MED12	5.11e-06	194	30	5	1060_UP
Drug	thiochrome	CACNA1A NCOA6	1.10e-04	12	30	2	CID000066706
Drug	Citalopram hydrobromide [59729-32-7]; Down 200; 1uM; MCF7; HT_HG-U133A	NALF1 ATRX NFAT5 EMSY	1.18e-04	194	30	4	3903_DN
Drug	Pyridoxine hydrochloride [58-56-0]; Up 200; 19.4uM; HL60; HG-U133A	CIZ1 MED15 EP400 MED12	1.18e-04	194	30	4	1759_UP
Drug	troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A	MED15 SUPT20H INTS7 DENND4B	1.20e-04	195	30	4	1657_DN
Drug	Cefotaxime sodium salt [64485-93-4]; Up 200; 8.4uM; PC3; HT_HG-U133A	SMARCD1 NFAT5 INTS7 EMSY	1.22e-04	196	30	4	2072_UP
Drug	Isoetharine mesylate salt [7279-75-6]; Down 200; 12uM; PC3; HT_HG-U133A	SUPT20H ATRX NFAT5 MED12	1.22e-04	196	30	4	5812_DN
Drug	Zidovudine, AZT [30516-87-1]; Down 200; 15uM; HL60; HG-U133A	AAK1 MED15 EP400 INTS7	1.27e-04	198	30	4	1595_DN
Drug	Oxybutynin chloride [1508-65-2]; Up 200; 10.2uM; PC3; HT_HG-U133A	AAK1 ZFHX3 SUPT20H NFAT5	1.27e-04	198	30	4	7126_UP
Drug	Ungerine nitrate; Up 200; 10.2uM; HL60; HT_HG-U133A	AAK1 SMARCD1 KMT2D NALF1	1.30e-04	199	30	4	2514_UP
Drug	Acyclovir [59277-89-3]; Down 200; 17.8uM; PC3; HG-U133A	AAK1 CIZ1 SMARCD1 SUPT20H	1.30e-04	199	30	4	1960_DN
Drug	Sotalol hydrochloride [959-24-0]; Down 200; 13uM; MCF7; HT_HG-U133A	MED15 SMARCD1 MED12 EMSY	1.30e-04	199	30	4	7338_DN
Drug	Convolamine hydrochloride [500-56-1]; Down 200; 11.8uM; PC3; HT_HG-U133A	CIZ1 MED15 ZFHX3 EMSY	1.30e-04	199	30	4	5876_DN
Drug	Alfuzosin hydrochloride [81403-68-1]; Down 200; 9.4uM; HL60; HG-U133A	AAK1 CIZ1 SUPT20H MED12	1.30e-04	199	30	4	1586_DN
Drug	Piribedil hydrochloride [78213-63-5]; Down 200; 12uM; PC3; HT_HG-U133A	MED15 SUPT20H NALF1 EP400	1.32e-04	200	30	4	6333_DN
Drug	Diflunisal [22494-42-4]; Up 200; 16uM; PC3; HG-U133A	CIZ1 SMARCD1 NFAT5 INTS7	1.32e-04	200	30	4	1908_UP
Disease	Phyllodes Tumor	KMT2D MED12	9.97e-06	5	30	2	C0010701
Disease	Malignant Cystosarcoma Phyllodes	KMT2D MED12	9.97e-06	5	30	2	C0600066
Disease	total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer	ZFHX3 SIK3 MAML3	4.75e-05	69	30	3	EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992
Disease	alcohol consumption measurement	CACNA1A ZFHX3 POU6F2 TMEM229A NALF1 NFAT5 LMX1A	2.00e-04	1242	30	7	EFO_0007878
Disease	tea consumption measurement	ZFHX3 POU6F2 NFAT5	3.04e-04	129	30	3	EFO_0010091
Disease	lung small cell carcinoma (is_implicated_in)	KMT2D ATRX	3.72e-04	28	30	2	DOID:5409 (is_implicated_in)
Disease	calcium measurement	AAK1 NCOA6 ZFHX3 SIK3 LMX1A	3.94e-04	628	30	5	EFO_0004838
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	ZFHX3 POU6F2 NFAT5 MAML3	4.84e-04	364	30	4	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	Borderline personality disorder	NALF1 MAML3	5.82e-04	35	30	2	HP_0012076
Disease	Malignant neoplasm of breast	SMARCD1 NCOA6 KMT2D SIK3 MED12 EMSY	6.43e-04	1074	30	6	C0006142
Disease	depressive symptom measurement	CACNA1A POU6F2 MAML3 MED12	8.72e-04	426	30	4	EFO_0007006
Disease	unipolar depression	GIGYF2 ZFHX3 TMEM229A NALF1 MAML3 MED12	1.18e-03	1206	30	6	EFO_0003761
Disease	body fat percentage	ZFHX3 POU6F2 NFAT5 MAML3	1.44e-03	488	30	4	EFO_0007800
Disease	PROSTATE CANCER, HEREDITARY, 1	EMSY DENND4B	1.71e-03	60	30	2	C4722327
Disease	urate measurement	AAK1 FMN2 NCOA6 NFAT5 INTS7	1.93e-03	895	30	5	EFO_0004531

Protein segments in the cluster

Peptide	Gene	Start	Entry
QQQQQQQQQQAVARP	CACNA1A	2316	O00555
FQLLRQQQQQQQQQQ	EP400	2751	Q96L91
QLMQNFYQQQQQQQQ	AAK1	526	Q2M2I8
LQQQQAQQPLQQQQQ	INTS7	941	Q9NVH2
QLQQQQQQQISQQPY	PAXIP1	426	Q6ZW49
QQFLREQRQQQQQQQ	MAML3	756	Q96JK9
RQQQQQQDQQNTQRL	LMX1A	256	Q8TE12
QRQQQQPQQQKQQQR	PDE5A	11	O76074
QQVALQQQQQQQQFQ	MED15	156	Q96RN5
QNQQQIQQQQQQLQR	MED15	226	Q96RN5
IAQLQLQQQQQQQQQ	MED15	241	Q96RN5
QQQQQQQQQQQYHIR	MED12	2066	Q93074
QQQQQQYHIRQQQQQ	MED12	2071	Q93074
QQQQQQILRQQQQQQ	MED12	2081	Q93074
QILRQQQQQQQQQQQ	MED12	2086	Q93074
QFQRQGLQQTQQQQQ	MED12	2136	Q93074
QQQQQQQQQQQSILF	NFAT5	1256	O94916
QQQQQQQQQQLQARP	NCOA6	276	Q14686
NRRLQQQYNQQQQQQ	ATRX	2411	P46100
NQQRQQQQLPQQQQQ	GIGYF2	1201	Q6Y7W6
RKQQQRQQQQQQQQK	C9orf43	291	Q8TAL5
LRERQQQQQQQQQQQ	DENND4B	891	O75064
QLYQVQQQTQQQVAQ	EMSY	411	Q7Z589
QQQQQQQLQLQLQQQ	FMN2	206	Q9NZ56
QQLQLQLQQQQQQQQ	FMN2	211	Q9NZ56
QQIQQVQQQAVQNRN	SMARCD1	106	Q96GM5
RRRQQQQQQQQQQQQ	TMEM229A	186	B2RXF0
QQQQQQQQQQRRGAL	TMEM229A	191	B2RXF0
QLQLQLQQQQQQQQQ	POU6F2	181	P78424
IKRQQQQRQQQQQQQ	SIK3	996	Q9Y2K2
RAAQQQKQQQQQQKQ	SHROOM4	1116	Q9ULL8
QQQQLQQQQQQLQQL	CIZ1	6	Q9ULV3
QQQQQQLQQLQQQQL	CIZ1	11	Q9ULV3
QQQQLQQQQLQQQQL	CIZ1	21	Q9ULV3
RQQQLQQQQQQGNKT	SOGA3	71	Q5TF21
FQQQQQQIQQLRFLQ	SUPT20H	726	Q8NEM7
QQLLQQQQEQLQQQQ	ZNF853	201	P0CG23
QQQEQLQQQQLLQQQ	ZNF853	206	P0CG23
LLQQQEQLQQQQFQQ	ZNF853	216	P0CG23
EQLQQQQFQQQQEQL	ZNF853	221	P0CG23
QQQEQLQQQQQQQLL	ZNF853	281	P0CG23
LQQQQQQQLLQQQQE	ZNF853	286	P0CG23
QQQLLQQQQEQLQQQ	ZNF853	291	P0CG23
RRRQQQQQQQQQQQQ	THAP11	101	Q96EK4
QQQQQRQLQQQQQQK	ZFHX3	3376	Q15911
RQLQQQQQQKVQQQQ	ZFHX3	3381	Q15911
LQQQQQLQQQQQQQL	KMT2D	3906	O14686
LQQQQLQQQQQQQQL	KMT2D	3926	O14686
QRQQQQQQQQQRQRQ	NALF1	76	B1AL88